• Je něco špatně v tomto záznamu ?

Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac Fibrosis

D. Liu, M. Wang, V. Murthy, DM. McNamara, TTL. Nguyen, TJ. Philips, H. Vyas, H. Gao, J. Sahni, RC. Starling, LT. Cooper, MK. Skime, A. Batzler, GD. Jenkins, S. Barlera, S. Pileggi, L. Mestroni, M. Merlo, G. Sinagra, F. Pinet, J. Krejčí, A....

. 2023 ; 133 (10) : 810-825. [pub] 20231006

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24000975

Grantová podpora
R01 HL164634 NHLBI NIH HHS - United States
R01 HL069071 NHLBI NIH HHS - United States
T32 GM008685 NIGMS NIH HHS - United States
R01 HL075038 NHLBI NIH HHS - United States
R01 HL116906 NHLBI NIH HHS - United States

BACKGROUND: Dilated cardiomyopathy (DCM) is a major cause of heart failure and carries a high mortality rate. Myocardial recovery in DCM-related heart failure patients is highly variable, with some patients having little or no response to standard drug therapy. A genome-wide association study may agnostically identify biomarkers and provide novel insight into the biology of myocardial recovery in DCM. METHODS: A genome-wide association study for change in left ventricular ejection fraction was performed in 686 White subjects with recent-onset DCM who received standard pharmacotherapy. Genome-wide association study signals were subsequently functionally validated and studied in relevant cellular models to understand molecular mechanisms that may have contributed to the change in left ventricular ejection fraction. RESULTS: The genome-wide association study identified a highly suggestive locus that mapped to the 5'-flanking region of the CDCP1 (CUB [complement C1r/C1s, Uegf, and Bmp1] domain containing protein 1) gene (rs6773435; P=7.12×10-7). The variant allele was associated with improved cardiac function and decreased CDCP1 transcription. CDCP1 expression was significantly upregulated in human cardiac fibroblasts (HCFs) in response to the PDGF (platelet-derived growth factor) signaling, and knockdown of CDCP1 significantly repressed HCF proliferation and decreased AKT (protein kinase B) phosphorylation. Transcriptomic profiling after CDCP1 knockdown in HCFs supported the conclusion that CDCP1 regulates HCF proliferation and mitosis. In addition, CDCP1 knockdown in HCFs resulted in significantly decreased expression of soluble ST2 (suppression of tumorigenicity-2), a prognostic biomarker for heart failure and inductor of cardiac fibrosis. CONCLUSIONS: CDCP1 may play an important role in myocardial recovery in recent-onset DCM and mediates its effect primarily by attenuating cardiac fibrosis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24000975
003      
CZ-PrNML
005      
20240213093533.0
007      
ta
008      
240109s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1161/CIRCRESAHA.123.323200 $2 doi
035    __
$a (PubMed)37800334
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Liu, Duan $u Departments of Molecular Pharmacology and Experimental Therapeutics (D.L., V.M., T.T.L.N., T.J.P., H.G., R.M.W., N.L.P.), Mayo Clinic, Rochester, MN $1 https://orcid.org/000000031065246X
245    10
$a Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac Fibrosis / $c D. Liu, M. Wang, V. Murthy, DM. McNamara, TTL. Nguyen, TJ. Philips, H. Vyas, H. Gao, J. Sahni, RC. Starling, LT. Cooper, MK. Skime, A. Batzler, GD. Jenkins, S. Barlera, S. Pileggi, L. Mestroni, M. Merlo, G. Sinagra, F. Pinet, J. Krejčí, A. Chaloupka, JD. Miller, P. de Groote, DJ. Tschumperlin, RM. Weinshilboum, NL. Pereira
520    9_
$a BACKGROUND: Dilated cardiomyopathy (DCM) is a major cause of heart failure and carries a high mortality rate. Myocardial recovery in DCM-related heart failure patients is highly variable, with some patients having little or no response to standard drug therapy. A genome-wide association study may agnostically identify biomarkers and provide novel insight into the biology of myocardial recovery in DCM. METHODS: A genome-wide association study for change in left ventricular ejection fraction was performed in 686 White subjects with recent-onset DCM who received standard pharmacotherapy. Genome-wide association study signals were subsequently functionally validated and studied in relevant cellular models to understand molecular mechanisms that may have contributed to the change in left ventricular ejection fraction. RESULTS: The genome-wide association study identified a highly suggestive locus that mapped to the 5'-flanking region of the CDCP1 (CUB [complement C1r/C1s, Uegf, and Bmp1] domain containing protein 1) gene (rs6773435; P=7.12×10-7). The variant allele was associated with improved cardiac function and decreased CDCP1 transcription. CDCP1 expression was significantly upregulated in human cardiac fibroblasts (HCFs) in response to the PDGF (platelet-derived growth factor) signaling, and knockdown of CDCP1 significantly repressed HCF proliferation and decreased AKT (protein kinase B) phosphorylation. Transcriptomic profiling after CDCP1 knockdown in HCFs supported the conclusion that CDCP1 regulates HCF proliferation and mitosis. In addition, CDCP1 knockdown in HCFs resulted in significantly decreased expression of soluble ST2 (suppression of tumorigenicity-2), a prognostic biomarker for heart failure and inductor of cardiac fibrosis. CONCLUSIONS: CDCP1 may play an important role in myocardial recovery in recent-onset DCM and mediates its effect primarily by attenuating cardiac fibrosis.
650    _2
$a lidé $7 D006801
650    12
$a dilatační kardiomyopatie $x metabolismus $7 D002311
650    _2
$a tepový objem $7 D013318
650    _2
$a celogenomová asociační studie $7 D055106
650    _2
$a funkce levé komory srdeční $7 D016277
650    12
$a srdeční selhání $7 D006333
650    _2
$a fibróza $7 D005355
650    _2
$a antigeny nádorové $x terapeutické užití $7 D000951
650    _2
$a molekuly buněčné adheze $x metabolismus $7 D015815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Wang, Min $u Cardiovascular Medicine (M.W., V.M., H.V., J.S., N.L.P.), Mayo Clinic, Rochester, MN $1 https://orcid.org/0000000167599132
700    1_
$a Murthy, Vishakantha $u Departments of Molecular Pharmacology and Experimental Therapeutics (D.L., V.M., T.T.L.N., T.J.P., H.G., R.M.W., N.L.P.), Mayo Clinic, Rochester, MN $u Cardiovascular Medicine (M.W., V.M., H.V., J.S., N.L.P.), Mayo Clinic, Rochester, MN $u Medicine (V.M.), Mayo Clinic, Rochester, MN $1 https://orcid.org/0000000332795322
700    1_
$a McNamara, Dennis M $u Department of Medicine, University of Pittsburgh, PA (D.M.M.)
700    1_
$a Nguyen, Thanh Thanh L $u Departments of Molecular Pharmacology and Experimental Therapeutics (D.L., V.M., T.T.L.N., T.J.P., H.G., R.M.W., N.L.P.), Mayo Clinic, Rochester, MN
700    1_
$a Philips, Trudy J $u Departments of Molecular Pharmacology and Experimental Therapeutics (D.L., V.M., T.T.L.N., T.J.P., H.G., R.M.W., N.L.P.), Mayo Clinic, Rochester, MN
700    1_
$a Vyas, Hridyanshu $u Cardiovascular Medicine (M.W., V.M., H.V., J.S., N.L.P.), Mayo Clinic, Rochester, MN $1 https://orcid.org/0000000219291341
700    1_
$a Gao, Huanyao $u Departments of Molecular Pharmacology and Experimental Therapeutics (D.L., V.M., T.T.L.N., T.J.P., H.G., R.M.W., N.L.P.), Mayo Clinic, Rochester, MN $1 https://orcid.org/0000000294419579
700    1_
$a Sahni, Jyotan $u Cardiovascular Medicine (M.W., V.M., H.V., J.S., N.L.P.), Mayo Clinic, Rochester, MN $1 https://orcid.org/0000000270381190
700    1_
$a Starling, Randall C $u Department of Cardiovascular Medicine, Cleveland Clinic, OH (R.C.S.) $1 https://orcid.org/0000000212544860
700    1_
$a Cooper, Leslie T $u Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL (L.T.C.) $1 https://orcid.org/0000000310023313 $7 xx0281465
700    1_
$a Skime, Michelle K $u Psychiatry and Psychology (M.K.S.), Mayo Clinic, Rochester, MN $1 https://orcid.org/0000000178633017
700    1_
$a Batzler, Anthony $u Health Sciences Research (A.B., G.D.J.), Mayo Clinic, Rochester, MN $1 https://orcid.org/0000000337534930
700    1_
$a Jenkins, Gregory D $u Health Sciences Research (A.B., G.D.J.), Mayo Clinic, Rochester, MN
700    1_
$a Barlera, Simona $u Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy (S.B., S.P.)
700    1_
$a Pileggi, Silvana $u Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy (S.B., S.P.) $1 https://orcid.org/0000000243069476
700    1_
$a Mestroni, Luisa $u Division of Cardiology, Department of Medicine, Cardiovascular Institute, University of Colorado School of Medicine, Aurora (L.M.) $1 https://orcid.org/0000000311162286 $7 xx0196682
700    1_
$a Merlo, Marco $u Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Italy (M.M., G.S.)
700    1_
$a Sinagra, Gianfranco $u Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Italy (M.M., G.S.) $1 https://orcid.org/0000000327008478 $7 xx0196679
700    1_
$a Pinet, Florence $u Pôle Cardio-vasculaire et Pulmonaire, University Lille, Inserm, CHU Lille, Institut Pasteur de Lille, France (F.P., P.d.G.) $1 https://orcid.org/0000000254711487
700    1_
$a Krejčí, Jan $u First Department of Internal Medicine, Cardiology and Angiology, St. Anne's University Hospital and Masaryk University, Brno, Czech Republic (J.K., A.C.) $1 https://orcid.org/0000000344682843
700    1_
$a Chaloupka, Anna $u First Department of Internal Medicine, Cardiology and Angiology, St. Anne's University Hospital and Masaryk University, Brno, Czech Republic (J.K., A.C.) $1 https://orcid.org/000000017734474X
700    1_
$a Miller, Jordan D $u Cardiovascular Surgery (J.D.M.), Mayo Clinic, Rochester, MN
700    1_
$a de Groote, Pascal $u Pôle Cardio-vasculaire et Pulmonaire, University Lille, Inserm, CHU Lille, Institut Pasteur de Lille, France (F.P., P.d.G.) $u CHU Lille, Service de Cardiologie, France (P.d.G.) $1 https://orcid.org/0000000262110147
700    1_
$a Tschumperlin, Daniel J $u Physiology and Biomedical Engineering (D.J.T.), Mayo Clinic, Rochester, MN
700    1_
$a Weinshilboum, Richard M $u Departments of Molecular Pharmacology and Experimental Therapeutics (D.L., V.M., T.T.L.N., T.J.P., H.G., R.M.W., N.L.P.), Mayo Clinic, Rochester, MN
700    1_
$a Pereira, Naveen L $u Departments of Molecular Pharmacology and Experimental Therapeutics (D.L., V.M., T.T.L.N., T.J.P., H.G., R.M.W., N.L.P.), Mayo Clinic, Rochester, MN $u Cardiovascular Medicine (M.W., V.M., H.V., J.S., N.L.P.), Mayo Clinic, Rochester, MN $1 https://orcid.org/0000000338133469
773    0_
$w MED00001092 $t Circulation research $x 1524-4571 $g Roč. 133, č. 10 (2023), s. 810-825
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37800334 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213093530 $b ABA008
999    __
$a ok $b bmc $g 2049543 $s 1210669
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 133 $c 10 $d 810-825 $e 20231006 $i 1524-4571 $m Circulation research $n Circ Res $x MED00001092
GRA    __
$a R01 HL164634 $p NHLBI NIH HHS $2 United States
GRA    __
$a R01 HL069071 $p NHLBI NIH HHS $2 United States
GRA    __
$a T32 GM008685 $p NIGMS NIH HHS $2 United States
GRA    __
$a R01 HL075038 $p NHLBI NIH HHS $2 United States
GRA    __
$a R01 HL116906 $p NHLBI NIH HHS $2 United States
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Možnosti archivace